Aptevo Therapeutics (NASDAQ:APVO) Releases Earnings Results, Beats Expectations By $0.26 EPS
Aptevo Therapeutics (NASDAQ:APVO – Get Free Report) released its earnings results on Thursday. The biotechnology company reported ($1.67) earnings per share for the quarter, beating analysts’ consensus estimates of ($1.93) by $0.26, Zacks reports. Aptevo Therapeutics Price Performance Shares of Aptevo Therapeutics stock traded down $0.04 during trading on Friday, reaching $0.37. 134,978 shares of […]
More Stories
Uquid Coin (UQC) Tops 1-Day Trading Volume of $384,803.21
Uquid Coin (UQC) traded 2.1% higher against the U.S. dollar during the one day period ending at 12:00 PM ET...
Uquid Coin (UQC) Tops 1-Day Trading Volume of $384,803.21
Uquid Coin (UQC) traded 2.1% higher against the U.S. dollar during the one day period ending at 12:00 PM ET...
Amp Achieves Self Reported Market Capitalization of $291.94 Million (AMP)
Amp (AMP) traded up 1.4% against the dollar during the one day period ending at 12:00 PM ET on December...
Amp Achieves Self Reported Market Capitalization of $291.94 Million (AMP)
Amp (AMP) traded up 1.4% against the dollar during the one day period ending at 12:00 PM ET on December...
Blast 24 Hour Trading Volume Reaches $14.77 Million (BLAST)
Blast (BLAST) traded up 2.5% against the US dollar during the 24 hour period ending at 12:00 PM E.T. on...
Blast 24 Hour Trading Volume Reaches $14.77 Million (BLAST)
Blast (BLAST) traded up 2.5% against the US dollar during the 24 hour period ending at 12:00 PM E.T. on...